News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69,073 Results
Type
Article (1917)
Company Profile (2)
Press Release (67154)
Section
Business (21466)
Career Advice (9)
Deals (4552)
Drug Development (8160)
FDA (1803)
Job Trends (800)
News (37026)
Policy (3563)
Tag
Academia (91)
Alliances (8105)
Alzheimer's disease (117)
Approvals (1811)
Artificial intelligence (8)
Bankruptcy (8)
Best Places to Work (580)
Biosimilars (12)
Breast cancer (11)
Cancer (128)
Career advice (9)
Cell therapy (14)
Clinical research (6912)
Collaboration (49)
Compensation (5)
COVID-19 (179)
C-suite (7)
Data (127)
Diabetes (10)
Diagnostics (588)
Drug discovery (11)
Duchenne muscular dystrophy (6)
Earnings (7493)
Events (6862)
Executive appointments (30)
FDA (1877)
Funding (31)
Gene therapy (10)
GLP-1 (36)
Government (234)
Healthcare (1072)
Infectious disease (183)
Inflammatory bowel disease (14)
Intellectual property (6)
IPO (1607)
Job creations (240)
Job search strategy (9)
Layoffs (6)
Legal (944)
Liver cancer (15)
Lung cancer (21)
Lymphoma (7)
Manufacturing (21)
Medical device (1110)
Medtech (1111)
Mergers & acquisitions (2996)
Metabolic disorders (27)
Neuroscience (144)
NextGen Class of 2024 (219)
Non-profit (61)
Northern California (101)
Obesity (10)
Parkinson's disease (12)
Patents (11)
People (4915)
Phase I (1873)
Phase II (2886)
Phase III (2629)
Pipeline (48)
Postmarket research (241)
Preclinical (654)
Radiopharmaceuticals (21)
Rare diseases (17)
Real estate (598)
Regulatory (2531)
Reports (6)
Research institute (91)
Series A (10)
Southern California (89)
Startups (421)
Supply chain (5)
United States (829)
Vaccines (19)
Date
Last 7 days (64)
Last 30 days (210)
Last 365 days (3247)
2024 (3220)
2023 (3821)
2022 (7023)
2021 (6374)
2020 (5872)
2019 (3863)
2018 (3010)
2017 (3560)
2016 (3171)
2015 (4031)
2014 (3022)
2013 (2600)
2012 (2775)
2011 (2902)
2010 (2663)
Location
Africa (79)
Arizona (5)
Asia (21170)
Australia (2417)
California (219)
Canada (169)
China (96)
Connecticut (10)
Europe (12275)
Florida (10)
Illinois (13)
India (6)
Japan (40)
Kansas (5)
Maryland (61)
Massachusetts (152)
Minnesota (22)
New Jersey (112)
New York (89)
North Carolina (49)
Northern California (101)
Pennsylvania (33)
South America (105)
Southern California (89)
Texas (11)
Utah (7)
Virginia (10)
69,073 Results for "keymed ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Keymed Biosciences Announces 2023 Annual Results and Business Updates
Keymed Biosciences Inc. (HKEX: 02162) today announced its 2023 annual results, along with recent pipeline highlights and corporate updates.
March 26, 2024
·
9 min read
Keymed Biosciences Announces Safety and Efficacy Results of CM313 for Primary Immune Thrombocytopenia Published in NEJM
Keymed Biosciences Inc. announced that Lei Zhang/Renchi Yang’s team from the Institute of Hematology, Chinese Academy of Medical Sciences has recently published a research paper entitled “A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia” in the New England Journal of Medicine.
June 20, 2024
·
2 min read
Business
Keymed Biosciences Announces Interim Results for First Half of 2024
August 27, 2024
·
8 min read
Drug Development
Keymed Biosciences Announces Long-term Efficacy and Safety Data from a Phase III Clinical Trial of Stapokibart for the Treatment of Moderate-to-severe Atopic Dermatitis
Keymed Biosciences Inc. announced the long-term efficacy and safety data of a Phase III clinical trial of stapokibart injection in patients with moderate-to-severe atopic dermatitis has been released by way of oral presentation at the European Academy of Allergy and Clinical Immunology Congress 2024.
June 2, 2024
·
3 min read
Press Releases
WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024
November 28, 2024
·
4 min read
Press Releases
AI/ML Innovations to Acquire Quantum Sciences Ltd
December 10, 2024
·
4 min read
Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901
Keymed Biosciences Inc., and Lepu Biopharma Co., Ltd, jointly announce a global exclusive licence agreement with AstraZeneca for CMG901, a potential first-in-class Claudin 18.2 antibody drug conjugate.
February 23, 2023
·
3 min read
Press Releases
Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd
December 18, 2024
·
4 min read
Press Releases
Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.
December 11, 2024
·
3 min read
Press Releases
Wavegate Corporation Announces $26 Million Series A Funding Round Led by UCEA Capital Partners Ltd.
December 11, 2024
·
2 min read
1 of 6,908
Next
